Avsnitt
-
Listen in for reproductive health news updates and a discussion on self-managed abortion.
For more information on the topic please check out the following resources:
Grossman D, Verma N. Self-managed Abortion in the US. JAMA. 2022;328(17):1693–1694. doi:10.1001/jama.2022.19057
Ralph L, Foster DG, Raifman S, et al. Prevalence of Self-Managed Abortion Among Women of Reproductive Age in the United States. JAMA Netw Open. 2020;3(12):e2029245. doi:10.1001/jamanetworkopen.2020.29245
Aiken ARA, Starling JE, Scott JG, Gomperts R. Requests for Self-managed Medication Abortion Provided Using Online Telemedicine in 30 US States Before and After the Dobbs v Jackson Women’s Health Organization Decision. JAMA. 2022;328(17):1768–1770. doi:10.1001/jama.2022.18865
Resources mentioned in the episode:
-Euki: https://eukiapp.org/
-AidAccess
-Abortion on Demand
-Women on Web
-Plan C
-Just the Pill
-M&A (Miscarriage and Abortion) Hotline
-SASS (Self-Managed abortion, Safe and Supported)
-If/When/How
-
Saknas det avsnitt?
-
A discussion about medication abortion and the upcoming Supreme Court Case over the future of Mifepristone in the United States.
-
Join me as I talk about reproductive justice in honor of Black History Month and the amazing Black women who developed the concept. Then we'll talk about the Opill, the first over-the-counter hormonal birth control to be available in the United States, and Contraceptive Access.
For more information on the topics in this episode please see the following:
SisterSong: https://www.sistersong.net/
Power to Decide: https://powertodecide.org/what-we-do/contraceptive-deserts
Rice LW, Espey E, Fenner DE, Gregory KD, Askins J, LockwoodCJ. Universal access to contraception: women, families, and communitiesbenefit. Am J Obstet Gynecol. 2020 Feb;222(2):150.e1-150.e5. doi:10.1016/j.ajog.2019.09.014. Epub 2019 Sep 19. PMID: 31542250. benefit
ACOG Committee Opinion 615 Access to Contraception: https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2015/01/access-to-contraception
Sutton, M.Y. et al.(2021) ‘Racial and ethnic disparities in reproductive health services andoutcomes, 2020’, Obstetrics & Gynecology, 137(2), pp. 225–233.doi:10.1097/aog.0000000000004224.
Clare, C.A. et al.(2021) ‘Contraception utilization in black women via a reproductive justicelens’, Breastfeeding Medicine, 16(12), pp. 935–937.doi:10.1089/bfm.2020.0391.
Troutman, M., Rafique, S.and Plowden, T.C. (2020) ‘Are higher unintended pregnancy rates amongminorities a result of disparate access to contraception?’, Contraceptionand Reproductive Medicine, 5(1). doi:10.1186/s40834-020-00118-5.
ACOG Committee Opinion788-Over the Counter Access to Hormonal Contraception: https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2019/10/over-the-counter-access-to-hormonal-contraception
Freethepill.org
Grandi G, Del Savio MC, Facchinetti F. The paradigm of norgestimate:a third-generation testosterone-derivative progestin with a peripheralanti-androgenic activity and the lowest risk of venous thromboembolism. ExpertRev Clin Pharmacol. 2021 Feb;14(2):211-224. doi: 10.1080/17512433.2021.1878876.Epub 2021 Jan 26. PMID: 33464138.
KFF Women’s health Survey, Over The Counter OralContraceptive Pills:https://www.kff.org/womens-health-policy/issue-brief/over-the-counter-oral-contraceptive-pills/#:~:text=the%2DCounter%20Access-,The%20nationally%20representative%202022%20KFF%20Women's%20Health%20Survey%20found%20that,they%20would%20be%20likely%20to
FDA The O-Pill: https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/opill-0075mg-oral-norgestrel-tablet-information
Grossman D, Fernandez L, Hopkins K, Amastae J, Garcia SG,Potter JE. Accuracy of self-screening for contraindications to combined oralcontraceptive use. Obstet Gynecol. 2008 Sep;112(3):572-8. doi:10.1097/AOG.0b013e31818345f0. PMID: 18757654; PMCID: PMC2615461.
Beat Provided By https://freebeats.io
Produced By White Hot
